000 | 01476 a2200385 4500 | ||
---|---|---|---|
005 | 20250514063815.0 | ||
264 | 0 | _c20031124 | |
008 | 200311s 0 0 eng d | ||
022 | _a0007-1188 | ||
024 | 7 |
_a10.1038/sj.bjp.0705163 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOrdan, Orly | |
245 | 0 | 0 |
_aStress-responsive JNK mitogen-activated protein kinase mediates aspirin-induced suppression of B16 melanoma cellular proliferation. _h[electronic resource] |
260 |
_bBritish journal of pharmacology _cMar 2003 |
||
300 |
_a1156-62 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnticarcinogenic Agents _xmetabolism |
650 | 0 | 4 |
_aAspirin _xpharmacology |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aGenes, jun _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aJNK Mitogen-Activated Protein Kinases |
650 | 0 | 4 | _aMAP Kinase Kinase 4 |
650 | 0 | 4 |
_aMelanoma, Experimental _xpathology |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinase Kinases _xmetabolism |
650 | 0 | 4 |
_aOrganophosphates _xmetabolism |
650 | 0 | 4 |
_aSuppression, Genetic _xdrug effects |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aRotem, Ronit | |
700 | 1 | _aJaspers, Ilona | |
700 | 1 | _aFlescher, Eliezer | |
773 | 0 |
_tBritish journal of pharmacology _gvol. 138 _gno. 6 _gp. 1156-62 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0705163 _zAvailable from publisher's website |
999 |
_c12476399 _d12476399 |